Kommersant: in Russia there was a shortage of drugs from Parkinson's disease
In Russia, there was a shortage of vital drugs with levodopa, which daily need 70% of almost 300 thousand patients with Parkinson's disease. The drugs of Israeli companies Teva and Hoffmann-la Roche began to disappear a year ago: the pricing methodology made their supplies "economically inappropriate." Now, in a crisis, the Russians cannot independently buy medicines abroad, and due to rising prices for the substance, the production of generics also curls up.